Cyclooxygenase-2 (COX-2)–independent anticarcinogenic effects of selective COX-2 inhibitors S Grösch, TJ Maier, S Schiffmann, G Geisslinger Journal of the National Cancer Institute 98 (11), 736-747, 2006 | 616 | 2006 |
Chain length-specific properties of ceramides S Grösch, S Schiffmann, G Geisslinger Progress in lipid research 51 (1), 50-62, 2012 | 536 | 2012 |
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer E Ruckhäberle, A Rody, K Engels, R Gaetje, G Von Minckwitz, ... Breast cancer research and treatment 112, 41-52, 2008 | 357 | 2008 |
Ceramide synthases and ceramide levels are increased in breast cancer tissue S Schiffmann, J Sandner, K Birod, I Wobst, C Angioni, E Ruckhäberle, ... Carcinogenesis 30 (5), 745-752, 2009 | 264 | 2009 |
DNA: a programmable force sensor C Albrecht, K Blank, M Lalic-Multhaler, S Hirler, T Mai, I Gilbert, ... Science 301 (5631), 367-370, 2003 | 233 | 2003 |
Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth D Hartmann, J Lucks, S Fuchs, S Schiffmann, Y Schreiber, N Ferreirós, ... The international journal of biochemistry & cell biology 44 (4), 620-628, 2012 | 232 | 2012 |
Ceramides as novel disease biomarkers J Kurz, MJ Parnham, G Geisslinger, S Schiffmann Trends in molecular medicine 25 (1), 20-32, 2019 | 170 | 2019 |
The enigma of ceramide synthase regulation in mammalian cells MS Wegner, S Schiffmann, MJ Parnham, G Geisslinger, S Grösch Progress in lipid research 63, 93-119, 2016 | 135 | 2016 |
Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti‐inflammatory phenotype A Weigert, S Schiffmann, D Sekar, S Ley, H Menrad, C Werno, S Grosch, ... International journal of cancer 125 (9), 2114-2121, 2009 | 123 | 2009 |
The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS D Hartmann, MS Wegner, RA Wanger, N Ferreirós, Y Schreiber, J Lucks, ... The international journal of biochemistry & cell biology 45 (7), 1195-1203, 2013 | 82 | 2013 |
A force-based protein biochip K Blank, T Mai, I Gilbert, S Schiffmann, J Rankl, R Zivin, C Tackney, ... Proceedings of the National Academy of Sciences 100 (20), 11356-11360, 2003 | 82 | 2003 |
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis s⃞ S Schiffmann, J Sandner, R Schmidt, K Birod, I Wobst, H Schmidt, ... Journal of lipid research 50 (1), 32-40, 2009 | 78 | 2009 |
Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S-or R-ibuprofen treatment A Janssen, TJ Maier, S Schiffmann, O Coste, M Seegel, G Geisslinger, ... European journal of pharmacology 540 (1-3), 24-33, 2006 | 75 | 2006 |
The anti-proliferative potency of celecoxib is not a class effect of coxibs S Schiffmann, TJ Maier, I Wobst, A Janssen, H Corban-Wilhelm, ... Biochemical pharmacology 76 (2), 179-187, 2008 | 73 | 2008 |
Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16: 0-ceramide S Schiffmann, S Ziebell, J Sandner, K Birod, K Deckmann, D Hartmann, ... Biochemical pharmacology 80 (11), 1632-1640, 2010 | 72 | 2010 |
Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils J Barthelmes, AM de Bazo, Y Pewzner-Jung, K Schmitz, CA Mayer, ... Brain, behavior, and immunity 46, 280-292, 2015 | 63 | 2015 |
Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis S Schiffmann, N Ferreiros, K Birod, M Eberle, Y Schreiber, W Pfeilschifter, ... The Journal of Immunology 188 (11), 5723-5733, 2012 | 61 | 2012 |
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy J Lötsch, S Schiffmann, K Schmitz, R Brunkhorst, F Lerch, N Ferreiros, ... Scientific reports 8 (1), 14884, 2018 | 60 | 2018 |
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis K Schmitz, R Brunkhorst, N De Bruin, CA Mayer, A Häussler, N Ferreiros, ... Acta neuropathologica communications 5, 1-18, 2017 | 58 | 2017 |
Inhibitors of specific ceramide synthases S Schiffmann, D Hartmann, S Fuchs, K Birod, N Ferreiròs, Y Schreiber, ... Biochimie 94 (2), 558-565, 2012 | 56 | 2012 |